Clinical trial reportJournal for immunotherapy of cancerPublished
Phase II study of nivolumab and salvage nivolumab/ipilimumab in treatment-naïve patients with advanced non-clear cell renal cell carcinoma (HCRN GU16-260-Cohort B)
Regional connection
Verified Author affiliations on the Europe PMC record name Fox Chase Cancer Center, Penn Medicine, with Temple Health linked by the institution reference. Affiliation source
- Institutions
- Fox Chase Cancer Center, Penn Medicine, Temple Health
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- Journal for immunotherapy of cancer
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Sarcoma; Carcinoma, Renal Cell; Soft Tissue Neoplasms; Salvage Therapy; Ipilimumab; Nivolumab; Immunotherapy; Kidney neoplasms; Clinical Trials, Phase Ii As Topic
- PubMed ID
- 36948504
- PubMed Central ID
- PMC10040058
- Open access
- Yes, open
- Added to directory
- Source checked